Metabolic activation of butylated hydroxytoluene by mouse bronchiolar Clara cells.
Metabolism of BHT (2,6-di-tert-butyl-4-methylphenol) is requisite for its pneumotoxic activities. Previous evidence using microsomal preparations from livers and lungs of mice indicated that cytochrome P450-catalyzed hydroxylation of a tertbutyl group to form 6-tert-butyl-2-(hydroxy-tert-butyl)-4-methylphenol (BHTOH) is the first step in the bioactivation of this compound. Subsequent oxidation of BHTOH produces the quinone methide 6-tert-butyl-2-(hydroxy-tert-butyl)-4-methylene-2,5-cyclohexadienone (BHTOH-QM), and this highly reactive electrophile may be directly responsible for the pulmonary effects of BHT. The present study assessed the ability of intact bronchiolar Clara cells isolated from mice, a major site of pulmonary xenobiotic metabolism, to convert BHT to BHTOH-QM. The data demonstrate that BHTOH is, in fact, the principal oxidation product in these cells, and that a substantial portion of this metabolite is oxidized further to the quinone methide. BHTOH was found to be considerably more toxic to Clara cells than BHT, and both toxicity and metabolism were simultaneously depressed by the cytochrome P450 inhibitor SKF 525-A. These results strongly support the hypothesis that BHTOH-QM is the active metabolite that generates acute pneumotoxicity and modulates lung tumor formation.
Bolton
J L
JL
Division of Pharmaceutical Sciences, School of Pharmacy, University of Colorado Health Sciences Center, Denver 80262.
Thompson
J A
JA
Allentoff
A J
AJ
Miley
F B
FB
Malkinson
A M
AM
D000818:Animals; D001711:Biotransformation; D002084:Butylated Hydroxytoluene / Q000493:pharmacokinetics* / Q000633:toxicity; D005260:Female; D008168:Lung / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D008175:Lung Neoplasms / Q000139:chemically induced; D008297:Male; D051379:Mice; D011335:Proadifen / Q000494:pharmacology
D002084:Butylated Hydroxytoluene; D011335:Proadifen